• Dec 31, 2024

Bitcoin more than doubles in 2024 on spot ETF approval, Trump euphoria

Bitcoin more than doubled in 2024 driven by the U.S. markets regulator's approval for exchange-traded funds tied to its spot price, and optimism over easing regulatory hurdles with Donald Trump set to return to the White House. On the other hand, several other crypto miners have reeled under shrinking margins due to higher energy and hardware costs, missing the year's rally.

  • Dec 31, 2024

Posh New York City Suburb to Tap Bond Market for $189 Million

(Bloomberg) -- Westchester County plans to issue roughly $189 million in general obligation bonds, with Fitch Ratings giving the debt a top-tier AAA rating. Most Read from BloombergDetroit’s Michigan Central Is the Building Revival Story of 2024Burned Out Parents Need Better Public SpacesMigrant Crisis Pushed US Homelessness to Record High in 2024The affluent enclave, home to New York City suburbs like Scarsdale and Rye, will use the proceeds from the sale expected in February for various capita

  • Dec 31, 2024

Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?

Kazia Therapeutics Limited (NASDAQ:KZIA) stock is trading lower on Tuesday after the company provided a regulatory update on paxalisib for glioblastoma (GBM) following its Type C clinical meeting with the FDA. In July 2024, the company reported topline results from the GBM-AGILE study in which newly diagnosed unmethylated patients with glioblastoma treated with paxalisib showed a clinically meaningful improvement in a prespecified secondary analysis for overall survival (OS) compared to standard